These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 7847600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.
    PLoS Med; 2015 Dec; 12(12):e1001924. PubMed ID: 26694529
    [Abstract] [Full Text] [Related]

  • 7. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
    Gual A, He Y, Torup L, van den Brink W, Mann K, ESENSE 2 Study Group.
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.
    Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S.
    J Clin Psychopharmacol; 2004 Aug; 24(4):421-8. PubMed ID: 15232334
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
    van den Brink W, Strang J, Gual A, Sørensen P, Jensen TJ, Mann K.
    Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F.
    Addiction; 2018 Feb; 113(2):220-237. PubMed ID: 28940866
    [Abstract] [Full Text] [Related]

  • 14. Nalmefene in alcohol-dependent patients with a high drinking risk: Randomized controlled trial.
    Miyata H, Takahashi M, Murai Y, Tsuneyoshi K, Hayashi T, Meulien D, Sørensen P, Higuchi S.
    Psychiatry Clin Neurosci; 2019 Nov; 73(11):697-706. PubMed ID: 31298784
    [Abstract] [Full Text] [Related]

  • 15. Changes in transaminases over the course of a 12-week, double-blind nalmefene trial in a 38-year-old female subject.
    Salvato FR, Mason BJ.
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1187-9. PubMed ID: 7847604
    [Abstract] [Full Text] [Related]

  • 16. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P, Blecha L.
    Encephale; 2014 Dec; 40(6):495-500. PubMed ID: 25454365
    [Abstract] [Full Text] [Related]

  • 17. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG.
    Adicciones; 2015 Sep 29; 27(3):214-30. PubMed ID: 26437315
    [Abstract] [Full Text] [Related]

  • 18. Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study.
    Quelch DR, Mick I, McGonigle J, Ramos AC, Flechais RSA, Bolstridge M, Rabiner E, Wall MB, Newbould RD, Steiniger-Brach B, van den Berg F, Boyce M, Østergaard Nilausen D, Breuning Sluth L, Meulien D, von der Goltz C, Nutt D, Lingford-Hughes A.
    Biol Psychiatry; 2017 Jun 01; 81(11):941-948. PubMed ID: 28216062
    [Abstract] [Full Text] [Related]

  • 19. Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY.
    Pharmacoeconomics; 2015 Aug 01; 33(8):833-47. PubMed ID: 25851485
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK, Scimeca M, Wu R, Malley SO.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):317-21. PubMed ID: 18644685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.